A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, vice president of venture capital at Medtronic (NYSE: MDT).
He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company (read more in his DeviceTalks speaker bio).
Medtronic has more than $500 million in venture investments, managed by Neustaedter’s group and others in the company. Every investment handled by his group requires two things.